Philogaline



Compound IDCDAMM02616
Common namePhilogaline
IUPAC name6,20,25-trimethoxy-23-oxa-15,30-diazaheptacyclo[22.6.2.13,7.18,12.114,18.027,31.022,33]pentatriaconta-1(30),3(35),4,6,8,10,12(34),14,18,20,22(33),24,26,31-tetradecaene-9,21-diol
Molecular formulaC35H32N2O6

Experimental data

Retention time16.18
Adduct[M+H]+
Actual mz577.23
Theoretical mz577.233
Error6.2
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.1761

Identifiers and class information

Inchi keyXFBNCBBULBPNCL-UHFFFAOYSA-N
SmilesOC1=CC=C2C=C1C3=CC(=CC=C3OC)CC4=NCCC=5C=C(OC)C(OC6=C(O)C(OC)=CC7=C6C(=NCC7)C2)=CC45
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)576.648
Computed dipole moment(dipole)6.45
Total solvent accessible surface area (SASA)829.865
Hydrophobic component of SASA (FOSA)527.298
Hydrophilic component of SASA (FISA)90.49
Pie component of the SASA (PISA)212.077
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1634.06
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)6.25
Free energy of solvation of dipole (dip^2/V)0.025462
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0106509
Globularity descriptor (glob)0.808481
Predicted polarizability in cubic angstroms (QPpolrz)53.561
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.886
Predicted octanol/gas partition coefficient (QPlogPoct)24.169
Predicted water/gas partition coefficient (QPlogPw)10.213
Predicted octanol/water partition coefficient (QPlogPo/w)6.407
Predicted aqueous solubility (QPlogS)-6.979
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.043
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.642
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1373.36
Predicted brain/blood partition coefficient (QPlogBB)-1.083
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)697.073
Predicted skin permeability, log Kp (QPlogKp)-1.288
PM3 calculated ionization potential (IP(ev))8.412
PM3 calculated electron affinity (EA(eV))0.328
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)1.273
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)94.702
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)86.66
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q15822CHRNA2Neuronal acetylcholine receptor; alpha2/beta2T55815SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T55815DI0101Corneal disease[ICD-11: 9A76-9A78]Q15822CHRNA2
T55815DI0117Depression[ICD-11: 6A70-6A7Z]Q15822CHRNA2
T55815DI0166Glaucoma[ICD-11: 9C61]Q15822CHRNA2
T55815DI0301Nicotine use disorder[ICD-11: 6C4A]Q15822CHRNA2
T55815DI0411Tonus and reflex abnormality[ICD-11: MB47]Q15822CHRNA2

Copyright © 2025